These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 6756393

  • 1. Characterization of [LeuB-24]- and [LeuB-25]-insulin analogues. Receptor binding and biological activity.
    Kobayashi M, Ohgaku S, Iwasaki M, Maegawa H, Shigeta Y, Inouye K.
    Biochem J; 1982 Sep 15; 206(3):597-603. PubMed ID: 6756393
    [Abstract] [Full Text] [Related]

  • 2. Immunoreactivity and biologic activity of semisynthetic [LeuB-30]-insulin: potential value in the treatment of insulin antibody-mediated insulin resistance.
    Kobayashi M, Ohgaku S, Iwasaki M, Shigeta Y, Oka T, Morihara K.
    Diabetes; 1981 Jun 15; 30(6):519-23. PubMed ID: 7014315
    [Abstract] [Full Text] [Related]

  • 3. Decreased biologic activity and degradation of human [SerB24]-insulin, a second mutant insulin.
    Haneda M, Kobayashi M, Maegawa H, Watanabe N, Takata Y, Ishibashi O, Shigeta Y, Inouye K.
    Diabetes; 1985 Jun 15; 34(6):568-73. PubMed ID: 3891469
    [Abstract] [Full Text] [Related]

  • 4. Receptor binding and biologic activity of biosynthetic human insulin and mini-proinsulin produced by recombinant gene technology.
    Kobayashi M, Sasaoka T, Sugibayashi M, Iwanishi M, Shigeta Y.
    Diabetes Res Clin Pract; 1989 Jun 20; 7(1):25-8. PubMed ID: 2666066
    [Abstract] [Full Text] [Related]

  • 5. Relationship between negative cooperativity and insulin action.
    Olefsky JM, Green A, Ciaraldi TP, Saekow M, Rubenstein AH, Tager HS.
    Biochemistry; 1981 Jul 21; 20(15):4488-92. PubMed ID: 7025901
    [Abstract] [Full Text] [Related]

  • 6. Receptor binding and biological activity of [SerB24]-insulin, an abnormal mutant insulin.
    Kobayashi M, Haneda M, Maegawa H, Watanabe N, Takada Y, Shigeta Y, Inouye K.
    Biochem Biophys Res Commun; 1984 Feb 29; 119(1):49-57. PubMed ID: 6367745
    [Abstract] [Full Text] [Related]

  • 7. Receptor binding and negative cooperativity of a mutant insulin, [LeuA3]-insulin.
    Kobayashi M, Takata Y, Ishibashi O, Sasaoka T, Iwasaki TM, Shigeta Y, Inouye K.
    Biochem Biophys Res Commun; 1986 May 29; 137(1):250-7. PubMed ID: 3521604
    [Abstract] [Full Text] [Related]

  • 8. Receptor binding and effect of biosynthetic human insulin on 2-deoxyglucose transport.
    Wieringa T, van Putten JP, Van Dijk-Besling M, Krans HM.
    Diabetes Care; 1981 May 29; 4(2):254-6. PubMed ID: 7011740
    [Abstract] [Full Text] [Related]

  • 9. Supernormal insulin: [D-PheB24]-insulin with increased affinity for insulin receptors.
    Kobayashi M, Ohgaku S, Iwasaki M, Maegawa H, Shigeta Y, Inouye K.
    Biochem Biophys Res Commun; 1982 Jul 16; 107(1):329-36. PubMed ID: 6751328
    [No Abstract] [Full Text] [Related]

  • 10. Degradation, receptor binding affinity, and potency of insulin from the Atlantic hagfish (Myxine glutinosa) determined in isolated rat fat cells.
    Gammeltoft S, Gliemann J.
    J Biol Chem; 1977 Jan 25; 252(2):602-8. PubMed ID: 556725
    [Abstract] [Full Text] [Related]

  • 11. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
    Záková L, Barth T, Jirácek J, Barthová J, Zórad S.
    Biochemistry; 2004 Mar 02; 43(8):2323-31. PubMed ID: 14979729
    [Abstract] [Full Text] [Related]

  • 12. The effect of triiodothyronine on insulin binding and action in rat adipocytes.
    Cech JM, Amatruda JM.
    Horm Metab Res; 1983 Nov 02; 15(11):530-2. PubMed ID: 6360843
    [Abstract] [Full Text] [Related]

  • 13. Insulin binding, biologic activity, and metabolism of biosynthetic human insulin.
    Olefsky JM.
    Diabetes Care; 1981 Nov 02; 4(2):244-7. PubMed ID: 7011736
    [Abstract] [Full Text] [Related]

  • 14. Role of guanine nucleotide regulatory proteins in insulin stimulation of glucose transport in rat adipocytes. Influence of bacterial toxins.
    Ciaraldi TP, Maisel A.
    Biochem J; 1989 Dec 01; 264(2):389-96. PubMed ID: 2557836
    [Abstract] [Full Text] [Related]

  • 15. Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin.
    Tager H, Thomas N, Assoian R, Rubenstein A, Saekow M, Olefsky J, Kaiser ET.
    Proc Natl Acad Sci U S A; 1980 Jun 01; 77(6):3181-5. PubMed ID: 6997872
    [Abstract] [Full Text] [Related]

  • 16. The biologic potency and binding affinity of biosynthetic human insulin in isolated rat adipocytes.
    Sonne O, Foley JE, Gliemann J.
    Diabetes Care; 1981 Jun 01; 4(2):250-1. PubMed ID: 7011738
    [Abstract] [Full Text] [Related]

  • 17. Characterization of insulin binding to isolated swine adipocytes.
    Etherton TD, Walker OA.
    Endocrinology; 1982 May 01; 110(5):1720-4. PubMed ID: 7042314
    [Abstract] [Full Text] [Related]

  • 18. [B17-D-leucine]insulin and [B17-norleucine]insulin: synthesis and biological properties.
    Knorr R, Danho W, Büllesbach EE, Gattner HG, Zahn H, King GL, Kahn CR.
    Hoppe Seylers Z Physiol Chem; 1983 Nov 01; 364(11):1615-26. PubMed ID: 6363268
    [Abstract] [Full Text] [Related]

  • 19. Binding of human, porcine and bovine insulin to insulin receptors from human brain, muscle and adipocytes and to expressed recombinant alternatively spliced insulin receptor isoforms.
    Kotzke G, Schütt M, Missler U, Moller DE, Fehm HL, Klein HH.
    Diabetologia; 1995 Jul 01; 38(7):757-63. PubMed ID: 7556975
    [Abstract] [Full Text] [Related]

  • 20. The A14 position of insulin tolerates considerable structural alterations with modest effects on the biological behavior of the hormone.
    Chu YC, Zong L, Burke GT, Katsoyannis PG.
    J Protein Chem; 1992 Oct 01; 11(5):571-7. PubMed ID: 1360216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.